Guess, and its just a hunch, around year end. It almost sounds like the pharma has done their due diligence and maybe waiting signing off with the various signatures which are required and can take a bit. He seemed very tight lipped about it which is encouraging. Had we said we are talking to pharmas about he prospects at play would be one thing, but he dropped out the partnership talks with a pharma in a q and a and almost seems to regret mentioning it--downplaying it. That's my two cents.
News 
Market Data 
Discover 
